Insider Trading & Ownership - Barrett Elizabeth A.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Barrett Elizabeth A.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-01-31
Sale
2022-02-02
4:32 pm
UroGen Pharma Ltd. URGN Barrett Elizabeth A.
Chief Executive Officer
8,195 $7.58 $62,118 490,025
(Direct)
View
2022-01-04
Sale
2022-01-07
08:38 am
UroGen Pharma Ltd. URGN Barrett Elizabeth A.
Chief Executive Officer
46,968 $9.15 $429,757 298,220
(Direct)
View
2020-12-14
Purchase
2020-12-15
5:27 pm
UroGen Pharma Ltd. URGN Barrett Elizabeth A.
Chief Executive Officer
10,000 $18.5 $185,000 229,117
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-01-31
Option Award
2025-02-04
11:49 am
N/A
N/A
UroGen Pharma Ltd. URGN Barrett Elizabeth A.
Chief Executive Officer
96,377 $0 96,377
(Direct)
View
2024-06-05
Option Award
2024-06-07
5:34 pm
N/A
2034-06-05
Allogene Therapeutics Inc. ALLO Barrett Elizabeth A.
Director
191,082 $0 191,082
(Direct)
View
2024-01-31
Option Award
2024-02-02
7:04 pm
N/A
N/A
UroGen Pharma Ltd. URGN Barrett Elizabeth A.
Chief Executive Officer
87,615 $0 87,615
(Direct)
View
2023-06-13
Option Award
2023-06-15
5:03 pm
N/A
2033-06-13
Allogene Therapeutics Inc. ALLO Barrett Elizabeth A.
Director
116,120 $0 116,120
(Direct)
View
2023-01-31
Exercise
2023-02-02
3:40 pm
N/A
N/A
UroGen Pharma Ltd. URGN Barrett Elizabeth A.
Chief Executive Officer
18,333 $0 640,025
(Direct)
View
2023-01-31
Option Award
2023-02-02
3:40 pm
N/A
N/A
UroGen Pharma Ltd. URGN Barrett Elizabeth A.
Chief Executive Officer
300,000 $0 640,025
(Direct)
View
2022-06-15
Option Award
2022-06-17
4:57 pm
N/A
2032-06-15
Allogene Therapeutics Inc. ALLO Barrett Elizabeth A.
Director
71,070 $0 71,070
(Direct)
View
2022-01-31
Exercise
2022-02-02
4:32 pm
N/A
N/A
UroGen Pharma Ltd. URGN Barrett Elizabeth A.
Chief Executive Officer
18,333 $0 490,025
(Direct)
View
2022-01-31
Option Award
2022-02-02
4:32 pm
N/A
2032-01-31
UroGen Pharma Ltd. URGN Barrett Elizabeth A.
Chief Executive Officer
150,000 $0 490,025
(Direct)
View
2022-01-03
Exercise
2022-01-07
08:38 am
N/A
N/A
UroGen Pharma Ltd. URGN Barrett Elizabeth A.
Chief Executive Officer
105,689 $0 298,220
(Direct)
View
2021-07-30
Option Award
2021-08-03
5:32 pm
N/A
2031-07-30
Allogene Therapeutics Inc. ALLO Barrett Elizabeth A.
Director
63,385 $0 63,385
(Direct)
View
2020-06-03
Exercise(A)
2021-07-12
6:59 pm
N/A
N/A
UroGen Pharma Ltd. URGN Barrett Elizabeth A.
Chief Executive Officer
61,652 $0 1,205,551
(Direct)
View
2021-01-03
Exercise
2021-05-21
1:44 pm
N/A
N/A
UroGen Pharma Ltd. URGN Barrett Elizabeth A.
Chief Executive Officer
13,807 $0 355,188
(Direct)
View
2021-05-19
Tax Withholding
2021-05-21
1:44 pm
N/A
N/A
UroGen Pharma Ltd. URGN Barrett Elizabeth A.
Chief Executive Officer
3,425 $17.51 355,188
(Direct)
View
2021-01-31
Option Award
2021-02-02
2:54 pm
N/A
2031-01-31
UroGen Pharma Ltd. URGN Barrett Elizabeth A.
Chief Executive Officer
190,000 $0 190,000
(Direct)
View
2020-12-04
Exercise
2020-12-04
4:35 pm
N/A
N/A
UroGen Pharma Ltd. URGN Barrett Elizabeth A.
Chief Executive Officer
61,652 $0 333,613
(Direct)
View

Ownership
2020-11-20
7:05 pm
N/A
N/A
Lifesci Acquisition II Corp. LSAQ Barrett Elizabeth A.
Director
0 $0 6,000
(Direct)
View
2020-05-12
Exercise
2020-05-14
1:07 pm
N/A
N/A
UroGen Pharma Ltd. URGN Barrett Elizabeth A.
Chief Executive Officer
35,229 $0 333,613
(Direct)
View
(A) Indicate amendment filing.